Peggy Chocarne Surville

Peggy Chocarne Surville currently serves as Directrice adjointe de la Direction des Autorisations at ANSM since November 2017, overseeing hematology and nephrology. Previously, from October 2011 to October 2017, Peggy held the role of Evaluateur bénéfice risque oncologie solide, where responsibilities included clinical evaluations and drafting related documents for various regulatory procedures. Peggy's career began at Afssaps from July 2005 to October 2011 as a clinical evaluator, focusing on drug efficacy and participating in European scientific advice and blood products working groups. Peggy holds multiple degrees in public health, biomedical research methodology, clinical trials, health product development, and cell biology from prestigious French universities, including Paris-Sud University and Université Paris Cité.